Search Results - "James, Angela J"

Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML by Pratz, Keith W, Cherry, Mohamad, Altman, Jessica K, Cooper, Brenda W, Podoltsev, Nikolai A, Cruz, Jose Carlos, Lin, Tara L, Schiller, Gary J, Jurcic, Joseph G, Asch, Adam, Wu, Ruishan, Hill, Jason E, Gill, Stanley C, James, Angela J, Rich, Elizabeth Shima, Hasabou, Nahla, Perl, Alexander E, Levis, Mark J

“…Gilteritinib is a type 1 FLT3 inhibitor active as monotherapy for relapsed or refractory -mutated AML. We investigated the safety, tolerability, and efficacy…”
Get full text

A Novel Approach to QTc Studies: Assessing Cardiac Safety of the mTOR Kinase Inhibitor CC-223 within the Dose-Escalation/Expansion Study by Kleiman, Robert B, Chopra, Rajesh, Hans, de Haan, Hege, Kristen, James, Angela J, Wang, Xiaomin, Wu, Xiaoling, O'Mara, Edward

“…Introduction: A variety of chemically diverse drugs are known to alter cardiac repolarization and to produce sudden cardiac death. Current regulatory…”
Get full text